Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: Results from a French national survey

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 3, 2014, Pages 288-294

  Abitbol, Vered ^a   Lahmek, Pierre ^c   Buisson, Anne ^b   Olympie, Alain ^b   Poupardin, Cécile ^d   Chaussade, Stanislas ^a   Lesgourgues, Bruno ^d   Nahon, Stéphane ^d  

^a Institut Cochin   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Emile Roux Hospital AP HP   (France)

^d NONE   (France)

Author keywords

Adherence; Complementary and alternative medicines; Compliance; Crohn's disease; Quality of life; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; COMPLEMENTARY THERAPIES; FEMALE; FRANCE; GASTROINTESTINAL AGENTS; HEALTH CARE SURVEYS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84895073384     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000040     Document Type: Article

References (34)

1. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JCC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 655-662.
2. National Center for Complementary and Alternative Medicine (NCCAM). What is complementary and alternative medicine? Available at: http://nccam.nih.gov/ health/whatiscam. [Accessed 17 May 2013].
3. Hilsden RJ, Meddings JB, Verhoef MJ. Complementary and alternative medicine use by patients with inflammatory bowel disease: an internet survey. Can J Gastroenterol 1999; 13: 327-332.
4. Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Löfberg R, Bohman L, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1298-1303.
5. Joos S, Rosemann T, Szecsenyi J, Hahn EG,Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006; 6:19.
6. Hilsden RJ, Verhoef MJ, Best A, Pocobelli G. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003; 98: 1563-1568.
7. Ganguli SC, Cawdron R, Irvine EJ. Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am J Gastroenterol 2004; 99: 319-326.
8. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8: 174-179.
9. Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005; 11: 287-295.
10. Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am J Gastroenterol 2004; 99: 889-893.
11. Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, BouchéO, et al. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. Gastroenterol Clin Biol 2006; 30: 14-23.
12. Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005; 39: 138-141.
13. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre J-P, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-656.
14. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 577-585.
15. Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001; 96: 2921-2928.
16. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996; 91: 1571-1578.
17. Hilsden RJ, Verhoef MJ. Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 318-323.
18. Opheim R, Bernklev T, Fagermoen MS, Cvancarova M, Moum B. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway. Scand J Gastroenterol 2012; 47: 1436-1447.
19. Rawsthorne P, Clara I, Graff LA, Bernstein KI, Carr R,Walker JR, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut 2012; 61: 521-527.
20. Sirois FM. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services. Complement Ther Med 2008; 16: 73-80.
21. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; 12: 1-23.
22. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012; 72: 803-823.
23. Zallot C, Quilliot D, Chevaux J-B, Peyrin-Biroulet C, Guéant-Rodriguez RM, Freling E, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 66-72.
24. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr 1997; 65: 564-567.
25. Petrak F, Hardt J, Clement T, Börner N, Egle UT, Hoffmann SO. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol 2001; 36: 375-382.
26. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002; 97: 1994-1999.
27. Nahon S, Lahmek P, Saas C, Durance C, Olympie A, Lesgourgues B, et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm Bowel Dis 2011; 17: 1270-1276.
28. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013; 144: 36-49.
29. García-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther 2004; 42: 367-383.
30. Gohar F, Greenfield SM, Beevers DG, Lip GYH, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008; 8:4.
31. Jernewall N, Zea MC, Reisen CA, Poppen PJ. Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men. AIDS Care 2005; 17: 601-609.
32. Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 342-349.
33. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1233-1239.
34. Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010; 4:63-101.